Your browser doesn't support javascript.
loading
Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study.
O'Sullivan, M A; O'Morain, C A.
Afiliación
  • O'Sullivan MA; Department of Gastroenterology, Adelaide & Meath Hospital, Tallaght, Dublin, Ireland.
Dig Liver Dis ; 32(4): 294-301, 2000 May.
Article en En | MEDLINE | ID: mdl-11515626
BACKGROUND: Symptoms of at least a subgroup of patients with irritable bowel syndrome may be associated with an alteration in gut flora. Studies on bacterial based therapy have yielded mixed results. AIMS: To determine if oral administration of the probiotic Lactobacillus casei strain GG under randomized placebo controlled conditions improves symptoms in irritable bowel syndrome patients with bloating related symptoms. PATIENTS: A total of 25 patients with clinically confirmed irritable bowel syndrome (Rome criteria) were enrolled in the study. METHODS: This was a randomised double-blind placebo-controlled crossover trial. Lactobacillus GG was administered as enterocoated tablets constituting a daily dosage of 10(10) colony forming units. Symptoms were assessed by daily symptom diaries and periodic questionnaires. RESULTS: Twenty-four patients were randomised; 19 (80%) female, mean age 40 years (range 24-60), mean duration of symptoms 4.9 years (range 0.5-18). Nineteen (80%) patients completed the study. No significant differences were found between Lactobacillus casei strain GG and placebo mean symptom scores for pain, urgency or bloating. A trend was noted, however, for a reduction in the number of unformed bowel motions on Lactobacillus casei strain GG treatment for patients with diarrhoea. CONCLUSIONS: Lactobacillus casei strain GG alone did not significantly improve symptoms in this irritable bowel syndrome subgroup. A "diarrhoea predominant" subgroup may warrant further investigation.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Funcionales del Colon / Probióticos / Lacticaseibacillus casei Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Dig Liver Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2000 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Países Bajos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Funcionales del Colon / Probióticos / Lacticaseibacillus casei Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Dig Liver Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2000 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Países Bajos